GWPH - GW Pharmaceuticals Q2 2020 Earnings Preview

August, 05 2020 01:28 PM GW Pharmaceuticals Plc

GW Pharmaceuticals (NASDAQ:GWPH) is scheduled to announce Q2 earnings results on Thursday, August 6th, after market close.
The consensus EPS Estimate is -$0.04 vs. $0.21 and the consensus Revenue Estimate is $124.26M (+72.5% Y/Y).
Analyst expects R&D expense of $47.1M.
Over the last 2 years, GWPH has beaten EPS estimates 50% of the time and has beaten revenue estimates 75% of the time.
Over the last 3 months, EPS estimates have seen 5 upward revisions and 2 downward. Revenue estimates have seen 7 upward revisions and 6 downward.
More news on: GW Pharmaceuticals plc, Earnings news and commentary, , Healthcare stocks news,